Gastrointestinal Stromal Tumor — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for gastrointestinal stromal tumor. 29 active patents protecting 1 drugs from 1+ originators. First major cliff: 2034. Daily refresh.

1
Approved drugs
29
Active US patents
58/100
Avg vulnerability
—
Annual revenue covered

Originators in Gastrointestinal Stromal Tumor

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Blueprint Medicines 29 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating gastrointestinal stromal tumor. Each bar = one year. Y-axis scaled to peak year (16 patents).

16
34
10
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Ayvakit
AVAPRITINIB
 Blueprint Medicines 29 58 — 2034-10-15

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12252494 Ayvakit method of use 75 2040-04-10
11999744 Ayvakit method of use 75 2040-04-10
11999744 Ayvakit method of use 75 2040-04-10
11999744 Ayvakit method of use 75 2040-04-10
11999744 Ayvakit method of use 75 2040-04-10
12060354 Ayvakit method of use 75 2042-03-08
12060354 Ayvakit method of use 75 2042-03-08
12060354 Ayvakit method of use 75 2042-03-08
11827642 Ayvakit method of use 70 2034-10-15
9200002 Ayvakit method of use 62 2034-10-15

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11964980 Ayvakit composition of matter 17 2040-04-10
11964980 Ayvakit composition of matter 17 2040-04-10
11964980 Ayvakit composition of matter 17 2040-04-10
11964980 Ayvakit composition of matter 17 2040-04-10
11964980 Ayvakit composition of matter 17 2040-04-10
9200002 Ayvakit method of use 62 2034-10-15
9944651 Ayvakit method of use 62 2034-10-15
9200002 Ayvakit method of use 62 2034-10-15
9944651 Ayvakit method of use 62 2034-10-15
9944651 Ayvakit method of use 62 2034-10-15

Related